Skip to main content

Table 1 Quantitative synthesis, bias assessment and credibility assessment of 74 associations between different comparisons of birth weight and health outcomes or traits

From: Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses

Reference

Outcome

Level of comparison

N cases/ N controls

N datasets

Effect size metric

Random-effects meta-analysis (95 % CI)

P value (random)

I2

95 % prediction intervals

P value for Egger test

P value for Excess significance test

Araujo de Franca, 2014 [59]

Waist circumference

Per 1 kg increase

4898d

6

Regression coefficient

−0.10 (−0.73 to 0.53)

0.760

73.2

−2.04 to 1.84

0.725

0.943

Araujo de Franca, 2014 [59]

Waist-to-hip ratio

Per 1 kg increase

5008d

10

Regression coefficient

−0.59 (−0.84 to −0.34)

4.0 × 10−6

0

−0.89 to −0.30

0.545

0.052

Baird, 2011 [48]

BMC in hip

Per 1 kg increase

1795d

6

Regression coefficient

1.42 (0.90 to 1.94)

8.3 × 10−8

5.9

0.56 to 2.28

0.584

0.838

Baird, 2011 [48]

BMC in lumbar spine

Per 1 kg increase

3181d

7

Regression coefficient

1.72 (0.76 to 2.67)

4.2 × 10−4

33.5

−0.53 to 3.97

0.069a

1.6 × 10−4

Baird, 2011 [48]

BMD in hip

Per 1 kg increase

3188d

7

Regression coefficient

0.01 (0.00 to 0.02)

0.235

0

−0.01 to 0.01

0.708

0.271

Baird, 2011 [48]

BMD in lumbar spine

Per 1 kg increase

3506d

8

Regression coefficient

0.00 (−0.01 to 0.01)

0.779

14.9

−0.02 to 0.02

0.831

0.341

Berhan, 2014 [46]

Perinatal mortality in developing countries

<2500 g vs. ≥ 2500 g

21,184/285,970

14

OR

9.59 (6.11 to 15.04)

7.5 × 10−23

98.9

1.43 to 64.18

0.954

0.707

Caughey, 2009 [13]

Acute lymphoblastic leukaemia

<2500 g vs. ≥ 2500 g

4805/765,827

10

RR

0.97 (0.81 to 1.16)

0.736

0

0.78 to 1.20

0.289

NP

Caughey, 2009 [13]

Acute lymphoblastic leukaemia

>4000 g vs. ≤ 4000 g

11,082/2,228,906

23

RR

1.29 (1.17 to 1.42)

1.9 × 10−7

36.3

0.97 to 1.72

0.055a

9.4 × 10−7

Caughey, 2009 [13]

Acute lymphoblastic leukaemia

Per 1 kg increase

7404/858,650

16

RR

1.19 (1.10 to 1.28)

1.7 × 10−5

54.7

0.93 to 1.52

0.990

2.2 × 10−4

Caughey, 2009 [13]

All types of leukaemia

<2500 g vs. ≥ 2500 g

5766/766,202

11

RR

1.04 (0.86 to 1.26)

0.683

10

0.76 to 1.43

0.357

NP

Caughey, 2009 [13]

All types of leukaemia

>4000 g vs. ≤ 4000 g

NA/NA

14

RR

1.42 (1.26 to 1.60)

1.2 × 10−8

28.5

1.07 to 1.88

0.001a

NA

Caughey, 2009 [13]

All types of leukaemia

Per 1 kg increase

11,313/861,710

21

RR

1.19 (1.12 to 1.27)

5.1 × 10−8

45.3

0.97 to 1.45

0.590

0.001

Caughey, 2009 [13]

Acute myeloid leukaemia

<2500 g vs. ≥ 2500 g

756/851,204

9

RR

1.46 (0.87 to 2.43)

0.151

43.7

0.39 to 5.43

0.606

NP

Caughey, 2009 [13]

Acute myeloid leukaemia

>4000 g vs. ≤ 4000 g

756/851,204

9

RR

1.25 (1.09 to 1.43)

1.3 × 10−3

43.9

0.88 to 1.77

0.216

3.1 × 10−4

Chen, 2012 [60]

Bone tumour

>4000 g vs. NBW

4044/272,354

8

OR

1.21 (0.97 to 1.50)

0.091

37.8

0.71 to 2.03

0.093a

0.396

Christian, 2013 [40]

Childhood stunting

SGA vs. AGA (BW ≥ 2500 g)

5413/16,663

10

OR

1.92 (1.75 to 2.12)

1.1 × 10−41

0

1.72 to 2.15

0.968

NP

Christian, 2013 [40]

Childhood stunting

SGA vs. AGA (BW < 2500 g)

843/1171

10

OR

3.00 (2.36 to 3.81)

2.3 × 10−19

56.6

1.53 to 5.85

0.555

NP

Cook, 2010 [58]

Testicular cancer

<2500 g vs. NBW

6906/612,741

17

OR

1.34 (1.08 to 1.67)

7.9 × 10−3

50.9

0.69 to 2.62

0.135

0.049

Davey-Smith, 2007 [61]

Maternal cardiovascular mortality

Per 1 SD increase

2976/974,667

6

HR

0.75 (0.67 to 0.84)

3.1 × 10−7

79.8

0.53 to 1.06

0.657

0.119

Davey-Smith, 2007 [61]

Paternal cardiovascular mortality

Per 1 SD increase

9375/774,325

3

HR

0.93 (0.91 to 0.95)

2.0 × 10−9

0

0.80 to 1.09

0.317

0.516

der Voort, 2014 [8]

Pre-school wheezing

<2500 g vs. NBW

40,603/103,271

26

OR

1.10 (1.00 to 1.21)

0.051

16

0.89 to 1.36

0.829

NP

der Voort, 2014 [8]

School-age asthma

<2500 g vs. NBW

11,729/121,198

16

OR

1.13 (1.01 to 1.27)

0.032

0

1.00 to 1.28

0.639

NP

Dodds, 2012 [62]

Muscle strength

Per 1 kg increase

20,461d

14

Regression coefficient

0.86 (0.58 to 1.15)

1.9 × 10−9

56.4

−0.01 to 1.74

0.965

NP

Harder, 2007 [7]

Type 2 diabetes mellitus

<2500 g vs. ≥ 2500 g

5815/100,759

10

OR

1.32 (1.06 to 1.64)

0.013

60.8

0.71 to 2.43

0.196

NP

Harder, 2007 [7]

Type 2 diabetes mellitus

>4000 g vs. ≤ 4000 g

6005/108,400

9

OR

1.27 (1.01 to 1.59)

0.044

68.2

0.62 to 2.58

0.817

NP

Harder, 2008 [63]

Astrocytoma

<2500 g vs. ≥ 2500 g

1574/160,146

6

OR

0.85 (0.58 to 1.25)

0.410

31.1

0.35 to 2.09

0.931

NP

Harder, 2008 [63]

Astrocytoma

>4000 g vs. ≤ 4000 g

1812/1,649,625

8

OR

1.38 (1.07 to 1.79)

0.014

57.5

0.66 to 2.88

0.632

0.160

Harder, 2008 [63]

Medulloblastoma

<2500 g vs. ≥ 2500 g

747/158,163

5

OR

1.65 (0.42 to 6.50)

0.475

88.2

0.01 to 223

0.828a

0.503

Harder, 2008 [63]

Medulloblastoma

>4000 g vs. ≤ 4000 g

853/1,647,552

7

OR

1.28 (1.02 to 1.59)

0.033

5.6

0.90 to 1.80

0.818

NP

Harder, 2009 [64]

Type 1 diabetes mellitus

<2500 g vs. ≥ 2500 g

5236/1,385,809

8

OR

0.82 (0.55 to 1.24)

0.344

91.4

0.20 to 3.31

0.067

NP

Harder, 2009 [64]

Type 1 diabetes mellitus

>4000 g vs. ≤ 4000 g

6406/2,388,046

10

OR

1.17 (1.09 to 1.26)

1.2 × 10−5

0

1.08 to 1.28

0.883

NP

Harder, 2010 [65]

Neuroblastoma

<2500 g vs. ≥ 2500 g

2907/2,156,535

10

OR

1.24 (0.99 to 1.55)

0.058

30.2

0.74 to 2.07

0.731

NP

Harder, 2010 [65]

Neuroblastoma

>4000 g vs. ≤ 4000 g

2856/2,156,654

10

OR

1.19 (1.04 to 1.36)

0.013

0

1.01 to 1.39

0.517

NP

Jackson 2013 [66]

Pneumonia in childhood

<2500 g vs. ≥ 2500 g

1281/1464

4

OR

3.18 (1.02 to 9.91)

0.046

95.6

0.01 to 714

0.366

NP

Kormos, 2013 [67]

Intelligence in adolescence

<2500 g vs. NBW

NA/NA

15

ORc

0.35 (0.27 to 0.45)

1.7 × 10−16

75.4

0.14 to 0.84

0.001a

7.8 × 10−4

Lawlor 2005 [68]

FEV1

Per 1 kg increase

5438d

7

Regression coefficient

0.06 (0.03 to 0.08)

1.4 × 10−5

36.5

−0.01 to 0.12

0.242

NP

Lawlor 2006 [69]

Total cholesterol in men

Per 1 kg increase

33,650d

34

Regression coefficient

−0.04 (−0.07 to −0.01)

0.018

49.8

−0.15 to 0.07

0.377

NP

Lawlor 2006 [69]

Total cholesterol in women

Per 1 kg increase

23,129d

34

Regression coefficient

−0.01 (−0.04 to 0.02)

0.510

27.7

−0.09 to 0.07

0.686

NP

Loret de Mola, 2014 [55]

Depression in adulthood

SGA vs. AGA

397/2844

5

OR

1.14 (0.64 to 2.03)

0.656

49.3

0.20 to 6.36

0.791

NP

Mebrahtu, 2015 [11]

Wheezing disorders in childhood

<2500 g vs. ≥ 2500 g

145,421/665,431

20

OR

1.61 (1.39 to 1.85)

1.1 × 10−10

82.3

0.92 to 2.80

0.021a

NP

Mebrahtu, 2015 [11]

Wheezing disorders in childhood

>4000 g vs. NBW

44,988/736,940

10

OR

1.02 (1.00 to 1.05)

0.100

0

0.99 to 1.05

0.985

NP

Michos, 2007 [70]

Testicular cancer

>4000 g vs. NBW

5684/123,120

10

OR

1.14 (0.99 to 1.31)

0.075

42.8

0.80 to 1.62

0.791

0.006

Milne, 2013 [56]

Acute lymphoblastic leukaemia

SGA vs. AGA

6835/11,689

12

OR

1.24 (1.13 to 1.36)

4.9 × 10−6

0

1.12 to 1.37

0.101

NP

Mu, 2012 [71]

Diastolic blood pressure

<2500 g vs. ≥ 2500 g

29,192d

15

ORc

4.45 (1.32 to 14.99)

0.016

99.3

0.02 to 902

0.085a

0.001

Mu, 2012 [71]

Systolic blood pressure

<2500 g vs. ≥ 2500 g

32,351d

19

ORc

7.45 (2.19 to 25.33)

1.3 × 10−3

99.4

0.02 to 2296

0.148

0.615

Mu, 2014 [41]b

Asthma in adulthood

<2500 g vs. ≥ 2500 g

2111/37,409

4

OR

1.25 (1.12 to 1.40)

7.7 × 10−5

0

0.98 to 1.60

0.884

NP

Øglund, 2015 [72]

Physical activity

Per 1 kg increase

10,667d

8

Regression coefficient

−3.08 (−10.20 to 4.04)

0.397

9

−14.81 to 8.66

0.881

NP

Papadopoulou, 2012 [73]

Hodgkin lymphoma in childhood

<2500 g vs. NBW

669/64,058

3

OR

0.94 (0.54 to 1.65)

0.829

0

0.03 to 35.25

0.344

NP

Papadopoulou, 2012 [73]

Non-Hodgkin lymphoma in childhood

<2500 g vs. NBW

1571/68,265

5

OR

1.07 (0.71 to 1.63)

0.740

55.4

0.29 to 3.95

0.599

NP

Papadopoulou, 2012 [73]

Non-Hodgkin lymphoma in childhood

>4000 g vs. NBW

1615/297,469

6

OR

1.17 (0.76 to 1.81)

0.473

66.7

0.32 to 4.28

0.085a

0.207

Panduru, 2013 [74]

Atopic dermatitis

<2500 g vs. NBW

6315/100,663

10

OR

0.66 (0.48 to 0.90)

9.1 × 10−3

85.6

0.23 to 1.87

0.558

0.412

Panduru, 2013 [74]

Atopic dermatitis

>4000 g vs. NBW

6224/62,672

6

OR

1.13 (0.97 to 1.31)

0.108

62.9

0.74 to 1.73

0.426

NP

Risnes, 2011 [42]b

All-cause mortality

<3000 g vs. NBW

32,926/276,648

8

HR

1.12 (1.07 to 1.16)

6.9 × 10−8

21.7

1.03 to 1.21

0.642

NP

Risnes, 2011 [42]b

All-cause mortality

>4000 g vs. NBW

32,926/276,648

8

HR

1.02 (0.98 to 1.05)

0.302

0

0.98 to 1.06

0.317

NP

Risnes, 2011 [42]b

All-cause mortality

Per 1 kg increase

36,834/361,874

18

HR

0.94 (0.92 to 0.97)

2.6 × 10−6

18.6

0.89 to 0.99

0.838

0.038

Risnes, 2011 [42]b

Mortality from cardiovascular diseases

Per 1 kg increase

11,366/314,715

16

HR

0.88 (0.85 to 0.91)

1.6 × 10−13

0

0.84 to 0.91

0.717

0.177

Risnes, 2011 [42]b

Mortality from cancer

Per 1 kg increase

9233/269,944

10

HR

1.09 (1.04 to 1.14)

3.4 × 10−4

20.8

0.99 to 1.19

0.276

0.037

Schellong, 2012 [43]b

Overweight/obese in adulthood

<2500 g vs. ≥ 2500 g

73,420/330,648

30

OR

0.67 (0.59 to 0.76)

1.1 × 10−9

82

0.38 to 1.18

0.079a

NP

Schellong, 2012 [43]b

Overweight/obese in adulthood

>4000 g vs. ≤ 4000 g

96,296/396,381

45

OR

1.68 (1.58 to 1.79)

3.6 × 10−57

74.9

1.24 to 2.28

0.133

NP

Silveira 2008 [75]

Metabolic syndrome

<2500 g vs. NBW

NA/NA

11

OR

2.54 (1.57 to 4.09)

1.4 × 10−4

39.2

0.75 to 8.60

0.204

NA

Shi, 2015 [76]

RSV-related acute lower respiratory infection in childhood

<2500 g vs. NBW

3383/155,872

5

OR

1.91 (1.45 to 2.53)

5.9 × 10−6

59.1

0.81 to 4.54

0.881

NP

van Montfoort, 2005 [77]

Cortisol levels

Per 1 kg increase

2301d

11

Regression coefficient

−20.49 (−35.97 to −5.00)

9.5 × 10−3

46.3

−61.37 to 20.4

0.524

NP

Wang, 2014 [9]

Coronary heart disease

<2500 g vs. ≥ 2500 g

13,089/360,209

16

OR

1.22 (1.13 to 1.31)

4.7 × 10−7

7

1.08 to 1.37

0.039a

0.751

Wang, 2014 [9]

Coronary heart disease

>4000 g vs. ≤ 4000 g

18,243/313,235

14

OR

0.89 (0.81 to 0.98)

0.019

47.4

0.68 to 1.16

0.226

NP

Wang, 2014 [9]

Coronary heart disease

Per 1 kg increase

NA/NA

23

OR

0.82 (0.78 to 0.86)

2.4 × 10−15

41.1

0.70 to 0.96

0.014a

NA

Whincup, 2008 [78]

Type 2 diabetes mellitus

Per 1 kg increase

6090/145,994

31

OR

0.80 (0.72 to 0.88)

1.8 × 10−5

66.5

0.52 to 1.21

0.286

0.355

White, 2009 [79]

Chronic kidney disease

<2500 g vs. NBW

NA/NA

21

OR

1.73 (1.44 to 2.08)

8.3 × 10−9

66.3

0.88 to 3.38

0.015a

NA

Wojcik, 2013 [14]b

Depression in adulthood

<2500 g vs. ≥ 2500 g

9013/50,428

18

OR

1.15 (1.00 to 1.32)

0.057

34.3

0.79 to 1.67

0.171

NP

Xu, 2009 [80]

Breast cancer

Per 1 kg increase

16,299/3,604,802

16

OR

1.08 (1.03 to 1.13)

2.8 × 10−3

22.5

0.97 to 1.20

0.452

4.1 × 10−4

Yang, 2014 [12]

Colorectal cancer

Per 1 kg increase

5985/723,087

5

RR

1.05 (0.93 to 1.19)

0.461

57.1

0.72 to 1.52

0.457

0.149

Yang, 2014 [12]

Endometrial cancer

Per 1 kg increase

3780/671,410

5

RR

0.91 (0.81 to 1.03)

0.128

40.2

0.65 to 1.27

0.867

0.758

Yang, 2014 [12]

Lung cancer

Per 1 kg increase

5207/696,742

4

RR

1.09 (1.02 to 1.16)

0.016

12.3

0.90 to 1.31

0.172

0.436

Yang, 2014 [12]

Melanoma

Per 1 kg increase

4000/3,821,122

6

RR

1.14 (1.05 to 1.24)

1.9 × 10−3

0

1.01 to 1.29

0.912

NP

Yang, 2014 [12]

Non-Hodgkin lymphoma

Per 1 kg increase

2056/626,082

3

RR

1.12 (1.01 to 1.24)

0.033

0

0.58 to 2.15

0.487

NP

Yang, 2014 [12]

Ovarian cancer

Per 1 kg increase

2880/805,887

5

RR

0.96 (0.88 to 1.04)

0.295

0

0.83 to 1.10

0.609

NP

Zhang, 2013 [81]

Diastolic blood pressure

>4000 g vs. NBW

150,980d

23

MD

0.19 (−0.23 to 0.62)

0.367

72.5

−1.39 to 1.79

0.792

NP

Zhang, 2013 [81]

Systolic blood pressure

>4000 g vs. NBW

151,935d

24

MD

−0.25 (−0.92 to 0.42)

0.466

79.3

−2.97 to 2.47

0.477

NP

  1. aBoth criteria for presence of small-study effects fulfilled (P value for Egger’s test < 0.10 and largest study with a smaller [more conservative] effect size than random-effects summary effect size)
  2. bThe highlighted papers performed a comparison between studies adjusting for and not adjusting for gestational age
  3. cRandom-effects summary effect size estimated from standardized mean difference transformed to odds ratio
  4. dIn meta-analyses with a continuous outcome, the total sample size is reported
  5. AGA adequate-for-gestational age, BMC bone mineral concentration, BMD bone mineral density, CI confidence interval, FEV 1 forced expiratory volume in the first second, HR hazard ratio, OR odds ratio, RR risk ratio, MD mean difference, NA not available, NBW normal birth weight, NP not pertinent (because the number of expected significant studies was larger than the number of observed significant studies), RSV respiratory syncytial virus, SD standard error, SGA small-for-gestational age